News and Events
Stay informed about RECOVER’s Long COVID research by reading the latest news and participating in upcoming events.
Featured News Item
Biosamples from RECOVER clinical trials offer expanded opportunities for Long COVID research
Biosamples collected during RECOVER clinical trials can provide valuable information about how people’s bodies respond to treatment. Researchers who receive funding through a new research opportunity can now access these samples.
Feature
179 Results
179 Results
RECOVER Representatives create resources for people living with Long COVID
Drawing on lived experience, RECOVER Representatives created 4 new resources to help people with Long COVID track symptoms, navigate work, find mental health support, and access financial assistance.
Feature
RECOVER launches new funding opportunity for pathobiology research
NIH invites investigators to apply for a new research opportunity, which funds pathobiology studies. Applicants can request use of data and biosamples from RECOVER observational studies and, for the first time, RECOVER clinical trials.
Announcement
RECOVER’s electronic health record study revealed early answers about COVID and Long COVID
RECOVER’s electronic health record study, which completed analyses in May, examined the health data of over 60 million people to advance Long COVID research.
Feature
New curriculum empowers future healthcare providers to recognize and treat Long COVID
A free online curriculum called LEARN prepares future healthcare providers to care for people with Long COVID. Built by doctors and students at 2 RECOVER study sites, LEARN bridges a gap some medical trainees see in their training.
Feature
R3 Seminar Recap: RECOVER clinical trial results and the pursuit of Long COVID treatments
During the July 14 RECOVER Research Review (R3) Seminar, panelists Craig Reist, PhD; David S. Knopman, MD; and Pam R. Taub, MD, shared findings from the RECOVER Clinical Trials (RECOVER-CT) program, the initiative's first wave of clinical trials. The trials focused on Long COVID symptoms related to thinking and memory, as well as the autonomic nervous system, which controls body functions like heart rate and blood pressure. RECOVER-CT Engagement Lead, Renee Leverty, MA, BSN, and Patient Representative Marta Cerda, JD, also explained how patient, caregiver, and community input shaped the trial design process.
R3 Seminar Recap
RECOVER at mid-year: 2026 progress and what’s ahead
In 2026 so far, RECOVER has published new research findings across nearly all its different studies and will soon be enrolling participants for the next phases of the adult observational study and clinical trials.
Feature
RECOVER to share clinical trial updates at July 2026 webinars
During 2 webinars, RECOVER researchers and leaders will discuss its clinical trial programs—RECOVER-CT and RECOVER-TLC, including clinical trial results to date and what it means to take part in a Long COVID clinical trial.
Feature
RECOVER-TLC to host next webinar July 16, 2026
NIH and FNIH leaders will provide an overview of the clinical trial process and updates on the status of RECOVER-TLC.
Announcement